Phargentis SA is a privately owned Virtual Drug Development Company located in Switzerland. Phargentis develops complex dosage forms enabling Early Market Entry Generic Drugs and innovative SuperGeneric products and deals with licensing-out to leading Pharma partners world-wide for market access.